Shares Lift Off Today, Up 5.17%Shares Lift Off Today, Up 5.17% to Close at $11.40
230,855 Shares Traded Today
CBLI Featured in Business Week
The article goes on to say,
“The military may be the first customer of little-known Cleveland BioLabs Inc. (CBLI) for its radiation protection compound called Protectan or CBLB502.
The company had responded to a Defense Dept. Request for Proposal in April. "It is likely Cleveland BioLabs will get a government contract for its product by summer's end," says Stephen Brozak of WBB Securities, who rates the stock a buy. It has rocketed from 4.80 in September, when it was first featured in this column, to 10.59 on June 20.
Brozak says no other product offers the same level of protection from radiation exposure. CEO Michael Fonstein says Protectan has the ability to mitigate the damaging effects of ionizing radiation on the gastrointestinal system and shows significant survival benefits suited to the Defense Dept.'s requirements.
Brozak says the contract could go as high as $200 million based on similar awards.
Walter Schenker of Titan Capital Management, which owns shares, says Protectan has shown effectiveness against radiation when applied two hours prior to exposure or up to eight hours after”